Marker Therapeutics (MRKR) Shares Outstanding (2010 - 2026)

Marker Therapeutics (MRKR) has 17 years of Shares Outstanding data on file, last reported at $16.7 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $16.7 million, up 48.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.7 million (up 48.91% YoY), and the FY2025 annual result was $16.7 million, up 55.94% from the prior year.
• Shares Outstanding was little changed at $16.7 million in Q1 2026 per MRKR's latest filing, from $16.7 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $16.7 million in Q3 2025 and troughed at $8.3 million in Q1 2022.
• A 5-year average of $10.5 million and a median of $8.9 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding tumbled 89.95% in 2022, then surged 87.15% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $8.4 million in 2022, then advanced by 5.78% to $8.9 million in 2023, then gained by 20.44% to $10.7 million in 2024, then surged by 55.94% to $16.7 million in 2025, then changed by 0.0% to $16.7 million in 2026.
• Business Quant data shows MRKR's Shares Outstanding at $16.7 million in Q1 2026, $16.7 million in Q4 2025, and $16.7 million in Q3 2025.